Molecular Biology In Young Women With Breast Cancer: From Tumor Gene Expression To DNA Mutations

Analysis of breast cancers from The Cancer Genome Atlas (TCGA) showed that HSD17B14 expression is increased significantly in cancer compared with normal breast tissue and that it

Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies. PIK3CA mutations in colorectal cancer

Informing women about the benefits and adverse effects of breast cancer screening could have an effect on their knowledge; their time perspective or their worry about breast cancer,

Conclusion Both TNM staging and histological/molecular biomarkers are associated with overall survival in Spanish women with breast cancer; when both are combined in the

(2013a) Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations. (2013b) Nonequivalent Gene

Pembrolizu- mab (P) in patients (pts) with metastatic breast cancer (MBC) with high tumor mutational burden (HTMB): results from the targeted agent and profiling utiliza- tion

Triple-negative breast cancer (TNBC) is am immunohistochemically-defined breast cancer subtype negative for ER, PR and HER2 expression, with dismal prognosis that

The two major breast cancer susceptibility genes BRCA1 and BRCA2 are involved in 30% of hereditary breast cancer cases, but the discovery of additional breast cancer